FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Xavier Montalban

Research Profile

Disorders

Chemicals & Drugs

Concepts & Ideas

Procedures

Disability Evaluation

Physiology

Co-author Network

Publications

TOP 3
Carmen Tur; Xavier Montalban
CSF oligoclonal bands are important in the diagnosis of multiple sclerosis, unreasonably downplayed by the McDonald Criteria 2010: No.
Óscar Fernández; Juan A García-Merino; Sergio Martínez-Yélamos; Lluís Ramió-Torrentà; Alfredo Rodríguez-Antigüedad; Mar Tintore; Manuel Comabella; Guillermo Izquierdo; José E Meca-Lallana; Celia Oreja-Guevara; José M Prieto; Luisa M Villar; José C Álvarez-Cermeño; Rafael Arroyo-González; Xavier Montalban
[Biomarkers in multiple sclerosis].
Mp Sormani; Ml Stromillo; B Stubinski; M Tintorè; D Li; Xavier Montalban; J Rio; A Signori; P Cornelisse; Nicola de Stefano
Scoring treatment response in patients with relapsing multiple sclerosis.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Xavier Montalban (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Carmen Tur; Xavier Montalban
CSF oligoclonal bands are important in the diagnosis of multiple sclerosis, unreasonably downplayed by the McDonald Criteria 2010: No.
Multiple sclerosis (Houndmills, Basingstoke, England) 2013;19(6):717-8.
2013: Óscar Fernández; Juan A García-Merino; Sergio Martínez-Yélamos; Lluís Ramió-Torrentà; Alfredo Rodríguez-Antigüedad; Mar Tintore; Manuel Comabella; Guillermo Izquierdo; José E Meca-Lallana; Celia Oreja-Guevara; José M Prieto; Luisa M Villar; José C Álvarez-Cermeño; Rafael Arroyo-González; Xavier Montalban
[Biomarkers in multiple sclerosis].
Revista de neurologia 2013;56(7):375-90.
2013: Mp Sormani; Ml Stromillo; B Stubinski; M Tintorè; D Li; Xavier Montalban; J Rio; A Signori; P Cornelisse; Nicola de Stefano
Scoring treatment response in patients with relapsing multiple sclerosis.
Multiple sclerosis (Houndmills, Basingstoke, England) 2013;19(5):605-12.
2013: S Malhotra; Xavier Montalban; A Vidal-Jordana; Mf Bustamante; J Castilló; Z Castro; Manuel Comabella
SIGLEC1 and SIGLEC7 expression in circulating monocytes of patients with multiple sclerosis.
Multiple sclerosis (Houndmills, Basingstoke, England) 2013;19(5):524-31.
2013: Manuel Comabella; K Borowski; M F Bustamante; K Rentzsch; Jordi Río; W Stoecker; Xavier Montalban
Treatment with interferon-β does not induce anti-nuclear and anti-neuronal serum autoantibodies in multiple sclerosis patients.
Journal of neuroimmunology 2013;255(1-2):102-4.
2013: S Otero-Romero; P Roura; Jaume Sastre-Garriga; J Solà; J Vaqué; J Altimiras; Xavier Montalban; Carlos Nos; E Bufill
Increase in the prevalence of multiple sclerosis over a 17-year period in Osona, Catalonia, Spain.
Multiple sclerosis (Houndmills, Basingstoke, England) 2013;19(2):245-8.
2013: Marta F Bustamante; Xavier Montalban; Ramil N Nurtdinov; Jordi Río; Manuel Comabella
Baseline Gene Expression Signatures in Monocytes from Multiple Sclerosis Patients Treated with Interferon-beta.
PloS one 2013;8(4):e60994.
2013: Georgina Arrambide; Nir Dotan; Avinoam Dukler; Carmen Espejo; Ella Fire; Xavier Montalban; Alex Rovira; Larissa Spector; Jennifer Yarden; Mar Tintore
Serum Biomarker gMS-Classifier2: Predicting Conversion to Clinically Definite Multiple Sclerosis.
PloS one 2013;8(3):e59953.
2013: Pino López-Méndez; Ariadna Pérez-Ricart; Jordi Río; Mar Tintore; Ignacio Cardona-Pascual; Jaume Sastre-Garriga; M Rosa Gómez-Domingo; Xavier Montalban
[Therapy adherence to immunomodulator treatment in patients with multiple sclerosis].
Revista de neurologia 2013;56(1):8-12.
2013: Antonio Alcina; Iraide Alloza; Alfredo Antigüedad; Rafael Arroyo; Yolanda Blanco; Manuel Comabella; Belén de la Hera; Maria Fedetz; Oscar Fernández; María J Garcia-Barcina; Juan-Antonio García-León; Guillermo Izquierdo; Laura Leyva; Miguel Lucas; Xavier Montalban; Arcadi Navarro; Javier Olascoaga; David Otaegui; Natalia Petit-Marty; Albert Saiz; Elena Urcelay; Koen Vandenbroeck; Jezabel Varade; María Del Mar Abad-Grau; Fuencisla Matesanz
Identification of a functional variant in the KIF5A-CYP27B1-METTL1-FAM119B locus associated with multiple sclerosis.
Journal of medical genetics 2013;50(1):25-33.
2012: Carmen Tur; M José Vicente; Angela Vidal-Jordana; Carlos Nos; Jordi Río; Jaume Sastre-Garriga; Mar Tintoré; M Jesús Arévalo; Georgina Arrambide; Ana Caminero; Joaquín Castilló; Manuel Comabella; Ingrid Galán; Rosalía Horno; Xavier Montalban
Natalizumab discontinuation after PML risk stratification: outcome from a shared and informed decision.
Multiple sclerosis (Houndmills, Basingstoke, England) 2012;18(8):1193-6.
2012: Carme Costa; Manuel Comabella; Xavier Montalban
[Stem cell-based treatment of neurologic diseases].
Medicina clínica 2012;139(5):208-14.
2012: Carmen Tur; Xavier Montalban
Subcutaneous alemtuzumab for multiple sclerosis.
Expert review of clinical immunology 2012;8(5):423-6.
2012: E Cantó; R Arroyo; A Caminero; C Domínguez; O Fernández; Alejandro Horga; G Izquierdo; Fuencisla Matesanz; Xavier Montalban; C Morcillo-Suárez; Arcadi Navarro; J Olascoaga; David Otaegui; F Reverter; A Rodríguez-Antigüedad; Albert Saiz; A Sanchez; Mar Tintoré; E Urcelay; Koen Vandenbroeck; Manuel Comabella
Chitinase 3-like 1 plasma levels are increased in patients with progressive forms of multiple sclerosis.
Multiple sclerosis (Houndmills, Basingstoke, England) 2012;18(7):983-90.
2012: Oscar Fernandez; Juan A Garcia-Merino; Miguel A Hernandez-Perez; Guillermo Izquierdo; José E Meca-Lallana; Xavier Montalban; Delicias Munoz-Garcia; Javier Olascoaga; Celia Oreja-Guevara; José M Prieto; Lluís Ramio-Torrenta; Alfredo Rodriguez-Antiguedad; Lucía Romero-Pinel; Fernando Sanchez; Nieves Tellez; Mar Tintore; José C Alvarez-Cermeno; Rafael Arroyo-Gonzalez; Luis Brieva; M Carmen Calles-Hernandez; Bonaventura Casanova-Estruch; Manuel Comabella; Virginia de Las Heras
Review of the novelties presented at the 27th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) (II).
Revista de neurologia 2012;54(12):734-49.
2012: Jordi Río; Jaume Sastre-Garriga; M Tintoré; C Tur; J Castilló; Manuel Comabella; C Nos; Xavier Montalban
Change in the clinical activity of multiple sclerosis after treatment switch for suboptimal response.
European journal of neurology : the official journal of the European Federation of Neurological Societies 2012;19(6):899-904.
2012: C Costa; Alejandro Horga; Georgina Arrambide; C Auger; J Castilló; Manuel Comabella; Carlos Nos; Jordi Río; Alex Rovira; Albert Saiz; Jaume Sastre-Garriga; Mar Tintore; C Tur; A Vidal-Jordana; Xavier Montalban
Value of NMO-IgG determination at the time of presentation as CIS.
Neurology 2012;78(20):1608-11.
2012: Manuel Comabella; Kristina Kakalacheva; Xavier Montalban; Christian Münz; Jordi Río; Jan D Lünemann
EBV-specific immune responses in patients with multiple sclerosis responding to IFNβ therapy.
Multiple sclerosis (Houndmills, Basingstoke, England) 2012;18(5):605-9.
2012: A Lopez de Lapuente; Xavier Montalban; Elena Urcelay; Iraide Alloza; A Antigüedad; Rafael Arroyo; Manuel Comabella; Robert Goertsches; U K Zettl; Koen Vandenbroeck
Analysis of the IL28RA locus as genetic risk factor for multiple sclerosis.
Journal of neuroimmunology 2012;245(1-2):98-101.
2012: Iraide Alloza; A Antigüedad; Rafael Arroyo; Y Blanco; Manuel Comabella; A Lopez de Lapuente; Maria Fedetz; O Fernandez; G Izquierdo; Laura Leyva; M Lucas; Fuencisla Matesanz; Xavier Montalban; Concepción Núñez; J Olascoaga; B Oliver-Martos; David Otaegui; A Saiz; Elena Urcelay; Antonio Alcina; Jezabel Varade; Koen Vandenbroeck
ANKRD55 and DHCR7 are novel multiple sclerosis risk loci.
Genes and immunity 2012;13(3):253-7.
2012: Nicolas Fissolo; Victor Llombart; María J Mansilla; Xavier Montalban; Ramil N Nurtdinov; Marta F Bustamante; Carme Costa; Carmen Espejo; Manuel Comabella
Treatment with MOG-DNA vaccines induces CD4+CD25+FoxP3+ regulatory T cells and up-regulates genes with neuroprotective functions in experimental autoimmune encephalomyelitis.
Journal of neuroinflammation 2012;9():139.
2012: María José Mansilla; Xavier Montalban; Carmen Espejo
Heat shock protein 70: roles in multiple sclerosis.
Molecular medicine (Cambridge, Mass.) 2012;18():1018-28.
2011: Jose E Martínez-Rodríguez; Xavier Montalban; Elvira Munteis; J Rio; Jaume Roquer; Miguel López-Botet; Manuel Comabella
Natural killer cell phenotype and clinical response to interferon-beta therapy in multiple sclerosis.
Clinical immunology (Orlando, Fla.) 2011;141(3):348-56.
2011: Carmen Tur; Jaume Sastre-Garriga; Nieves Téllez; Mar Tintoré; Francesc Xavier Aymerich; Luis Brieva; David Calle; Manuel Comabella; Ingrid Galán; Xavier Montalban; Carlos Nos; Héctor Perkal; Jordi Río; Alex Rovira
Interferon β-1b for the treatment of primary progressive multiple sclerosis: five-year clinical trial follow-up.
Archives of neurology 2011;68(11):1421-7.
2011: Xavier Montalban; P O'Connor; G Comi; A de Vera; B Eckert; Sm Gold; L Kappos
Oral fingolimod (FTY720) in relapsing multiple sclerosis: impact on health-related quality of life in a phase II study.
Multiple sclerosis (Houndmills, Basingstoke, England) 2011;17(11):1341-50.
2011: S Malhotra; F Martinelli Boneschi; Xavier Montalban; C Morcillo-Suárez; Arcadi Navarro; Jorge R Oksenberg; Jordi Río; A J Sánchez; E Urcelay; Koen Vandenbroeck; U K Zettl; Denis A Akkad; R Alvarez-Lafuente; David Brassat; M F Bustamante; A Chan; J Drulovic; O Fernández; Antonio García-Merino; G Giacalone; Robert Goertsches; J Lechner-Scott; L Leyva; Manuel Comabella
IL28B polymorphisms are not associated with the response to interferon-β in multiple sclerosis.
Journal of neuroimmunology 2011;239(1-2):101-4.
2011: Marta F Bustamante; Mari Carmen Edo; María Angeles Moro; Carme Costa; Carmen Espejo; Nicolás Fissolo; Ignacio Lizasoain; María José Mansilla; Xavier Montalban; Jordi Río; Manuel Comabella
Implication of the Toll-like receptor 4 pathway in the response to interferon-β in multiple sclerosis.
Annals of neurology 2011;70(4):634-45.
2011: Jordi Río; Manuel Comabella; Xavier Montalban
Multiple sclerosis: current treatment algorithms.
Current opinion in neurology 2011;24(3):230-7.
2011: Ana Caminero; Manuel Comabella; Xavier Montalban
Tumor necrosis factor alpha (TNF-α), anti-TNF-α and demyelination revisited: an ongoing story.
Journal of neuroimmunology 2011;234(1-2):1-6.
2011: Jaume Sastre-Garriga; Carlos Vila; Stephen Clissold; Xavier Montalban
THC and CBD oromucosal spray (Sativex®) in the management of spasticity associated with multiple sclerosis.
Expert review of neurotherapeutics 2011;11(5):627-37.
2011: Alejandro Horga; J Castillo; J Rio; Mar Tintore; C Auger; J Sastre-Garriga; M C Edo; Francisco Carlos Pérez-Miralles; C Tur; Carlos Nos; E Huerga; Manuel Comabella; Alex Rovira; Xavier Montalban
An observational study of the effectiveness and safety of natalizumab in the treatment of multiple sclerosis.
Revista de neurologia 2011;52(6):321-30.
2011: Nicolas Couturier; Florence Bucciarelli; Ramil N Nurtdinov; Marc Debouverie; Christine Lebrun-Frenay; Gilles Defer; Thibault Moreau; Christian Confavreux; Sandra Vukusic; Isabelle Cournu-Rebeix; Robert H Goertsches; Uwe K Zettl; Manuel Comabella; Xavier Montalban; Peter Rieckmann; Frank Weber; Bertram Müller-Myhsok; Gilles Edan; Bertrand Fontaine; Lennart T Mars; Abdelhadi Saoudi; Jorge R Oksenberg; Michel Clanet; Roland S Liblau; David Brassat
Tyrosine kinase 2 variant influences T lymphocyte polarization and multiple sclerosis susceptibility.
Brain : a journal of neurology 2011;134(Pt 3):693-703.
2011: Marco Rovaris; Maria A Rocca; Frederik Barkhof; Massimiliano Calabrese; Nicola de Stefano; Michael Khalil; Franz Fazekas; Leonora Fisniku; Paolo Gallo; David H Miller; Xavier Montalban; Chris Polman; Alex Rovira; Madeleine H Sombekke; Maria Pia Sormani; Maria Laura Stromillo; Massimo Filippi
Relationship between brain MRI lesion load and short-term disease evolution in non-disabling MS: a large-scale, multicentre study.
Multiple sclerosis (Houndmills, Basingstoke, England) 2011;17(3):319-26.
2011: Sunny Malhotra; Xavier Montalban; Lara Nonell; Ramil N Nurtdinov; Francisco Carlos Pérez-Miralles; Jordi Rio; Mari Carmen Ruiz de Villa; Esteban Vegas; Marta F Bustamante; Florian Deisenhammer; Nicolás Fissolo; Manuel Comabella
Search for specific biomarkers of IFNβ bioactivity in patients with multiple sclerosis.
PloS one 2011;6(8):e23634.
2011: B Bodini; M Battaglini; Nicola de Stefano; Zhaleh Khaleeli; Frederik Barkhof; Declan T Chard; Massimo Filippi; Xavier Montalban; Chris H Polman; Marco Rovaris; Alex Rovira; R Samson; David Miller; Alan Thompson; Olga Ciccarelli
T2 lesion location really matters: a 10 year follow-up study in primary progressive multiple sclerosis.
Journal of neurology, neurosurgery, and psychiatry 2011;82(1):72-7.
2010: Mar Tintore; Alex Rovira; Georgina Arrambide; R Mitjana; Jordi Río; C Auger; Carlos Nos; M C Edo; J Castilló; Alejandro Horga; Francisco Carlos Pérez-Miralles; E Huerga; Manuel Comabella; Jaume Sastre-Garriga; Xavier Montalban
Brainstem lesions in clinically isolated syndromes.
Neurology 2010;75(21):1933-8.
2010: Montse Camiña-Tato; Carlos Morcillo-Suárez; Marta F Bustamante; Israel Ortega; Arcadi Navarro; Aura Muntasell; Miguel López-Botet; Alex Sánchez; Paco Carmona; Eva Julià; María Teresa Tortola; Laura Audí; Jorge R Oksenberg; Roland Martin; Xavier Montalban; Manuel Comabella
Gender-associated differences of perforin polymorphisms in the susceptibility to multiple sclerosis.
Journal of immunology (Baltimore, Md. : 1950) 2010;185(9):5392-404.
2010: Manuel Comabella; Xavier Montalban; Christian Münz; Jan D Lünemann
Targeting dendritic cells to treat multiple sclerosis.
Nature reviews. Neurology 2010;6(9):499-507.
2010: Marta Fernández; Xavier Montalban; Manuel Comabella
Orchestrating innate immune responses in multiple sclerosis: molecular players.
Journal of neuroimmunology 2010;225(1-2):5-12.
2010: L V A E Bosma; J J Kragt; L Brieva; Z Khaleeli; Xavier Montalban; C H Polman; A J Thompson; Mar Tintoré; B M J Uitdehaag
Progression on the Multiple Sclerosis Functional Composite in multiple sclerosis: what is the optimal cut-off for the three components?
Multiple sclerosis (Houndmills, Basingstoke, England) 2010;16(7):862-7.
2010: Manuel Comabella; Xavier Montalban; Kristina Kakalacheva; Deeqa Osman; Falk Nimmerjahn; Mar Tintoré; Jan D Lünemann
B cell expression of the inhibitory Fc gamma receptor is unchanged in early MS.
Journal of neuroimmunology 2010;223(1-2):135-7.
2010: Alejandro Horga; Joaquín Castilló; Xavier Montalban
Fingolimod for relapsing multiple sclerosis: an update.
Expert opinion on pharmacotherapy 2010;11(7):1183-96.
2010: M Camiña-Tato; M Fernández; C Morcillo-Suárez; Arcadi Navarro; E Julià; M C Edo; Xavier Montalban; Manuel Comabella
Genetic association of CASP8 polymorphisms with primary progressive multiple sclerosis.
Journal of neuroimmunology 2010;222(1-2):70-5.
2010: Jaume Sastre-Garriga; Mar Tintoré; Carlos Nos; C Tur; Jordi Río; Nieves Téllez; J Castilló; Alejandro Horga; H Perkal; Manuel Comabella; Alex Rovira; Xavier Montalban
Clinical features of CIS of the brainstem/cerebellum of the kind seen in MS.
Journal of neurology 2010;257(5):742-6.
2010: Manuel Comabella; Marta Fernández; Roland Martin; Stephanie Rivera-Vallvé; Eva Borrás; Cristina Chiva; Eva Julià; Alex Rovira; Ester Cantó; Jose Carlos Alvarez-Cermeño; Luisa María Villar; Mar Tintoré; Xavier Montalban
Cerebrospinal fluid chitinase 3-like 1 levels are associated with conversion to multiple sclerosis.
Brain : a journal of neurology 2010;133(Pt 4):1082-93.
2010: Manuel Comabella; Xavier Montalban; Alejandro Horga; B Messmer; K Kakalacheva; T Strowig; E Caballero; C Münz; Jd Lünemann
Antiviral immune response in patients with multiple sclerosis and healthy siblings.
Multiple sclerosis (Houndmills, Basingstoke, England) 2010;16(3):355-8.
2010: Xavier Montalban; Mar Tintoré; J Swanton; F Barkhof; F Fazekas; M Filippi; J Frederiksen; L Kappos; J Palace; C Polman; Marco Rovaris; N de Stefano; A Thompson; T Yousry; Alex Rovira; D H Miller
MRI criteria for MS in patients with clinically isolated syndromes.
Neurology 2010;74(5):427-34.
2009: Xavier Montalban
Early treatment: PreCISe-ly what the patient needs.
Journal of the neurological sciences 2009;287 Suppl 1():S2-6.
2009: Xavier Montalban; Jaume Sastre-Garriga; M Filippi; Z Khaleeli; Nieves Téllez; M M Vellinga; C Tur; B Brochet; F Barkhof; Marco Rovaris; D H Miller; C H Polman; Alex Rovira; A J Thompson
Primary progressive multiple sclerosis diagnostic criteria: a reappraisal.
Multiple sclerosis (Houndmills, Basingstoke, England) 2009;15(12):1459-65.
2009: Manuel Comabella; J D Lünemann; Jordi Río; Armand Sánchez; C López; E Julià; M Fernández; L Nonell; M Camiña-Tato; F Deisenhammer; E Caballero; M T Tortola; M Prinz; Xavier Montalban; Roland Martin
A type I interferon signature in monocytes is associated with poor response to interferon-beta in multiple sclerosis.
Brain : a journal of neurology 2009;132(Pt 12):3353-65.
2009: Eva Julià; Mari Carmen Edo; Alex Horga; Xavier Montalban; Manuel Comabella
Differential susceptibility to apoptosis of CD4+T cells expressing CCR5 and CXCR3 in patients with MS.
Clinical immunology (Orlando, Fla.) 2009;133(3):364-74.
2009: Bastiaan Moraal; Christoph Pohl; Bernard M J Uitdehaag; Chris H Polman; Gilles Edan; Mark S Freedman; Hans-Peter Hartung; Ludwig Kappos; David H Miller; Xavier Montalban; Vivian Lanius; Rupert Sandbrink; Frederik Barkhof
Magnetic resonance imaging predictors of conversion to multiple sclerosis in the BENEFIT study.
Archives of neurology 2009;66(11):1345-52.
2009: Manuel Comabella; J M Pradillo; M Fernández; Jordi Río; I Lizasoain; E Julià; M A Moro; J Sastre-Garriga; Xavier Montalban
Plasma levels of 15d-PGJ are not altered in multiple sclerosis.
European journal of neurology : the official journal of the European Federation of Neurological Societies 2009;16(11):1197-201.
2009: Giancarlo Comi; Vittorio Martinelli; Mariemma Rodegher; L Moiola; O Bajenaru; A Carra; I Elovaara; Franz Fazekas; H P Hartung; J Hillert; J King; S Komoly; C Lubetzki; Xavier Montalban; K M Myhr; M Ravnborg; P Rieckmann; D Wynn; C Young; Massimo Filippi
Effect of glatiramer acetate on conversion to clinically definite multiple sclerosis in patients with clinically isolated syndrome (PreCISe study): a randomised, double-blind, placebo-controlled trial.
Lancet 2009;374(9700):1503-11.
2009: Jordi Río; Manuel Comabella; Xavier Montalban
Predicting responders to therapies for multiple sclerosis.
Nature reviews. Neurology 2009;5(10):553-60.
2009: Tijmen Korteweg; M Tintore; B M J Uitdehaag; Dirk L Knol; Hugo Vrenken; A Rovira; J Frederiksen; David H Miller; K Fernando; Massimo Filippi; F Agosta; M A Rocca; Franz Fazekas; C Enzinger; A Parry; Chris H Polman; Xavier Montalban; Frederik Barkhof
A search for new MRI criteria for dissemination in space in subjects with a clinically isolated syndrome.
European radiology 2009;19(9):2244-8.
2009: M Camiña-Tato; C Morcillo-Suárez; Arcadi Navarro; M Fernández; Alejandro Horga; Xavier Montalban; Manuel Comabella
Genetic association between polymorphisms in the BTG1 gene and multiple sclerosis.
Journal of neuroimmunology 2009;213(1-2):142-7.
2009: Manuel Comabella; David Craig; Carlos Morcillo-Suárez; Jordi Río; Arcadi Navarro; Marta Fernández; Roland Martin; Xavier Montalban
Genome-wide scan of 500,000 single-nucleotide polymorphisms among responders and nonresponders to interferon beta therapy in multiple sclerosis.
Archives of neurology 2009;66(8):972-8.
2009: L V A E Bosma; J J Kragt; L Brieva; Z Khaleeli; Xavier Montalban; C H Polman; A J Thompson; Mar Tintoré; B M J Uitdehaag
The search for responsive clinical endpoints in primary progressive multiple sclerosis.
Multiple sclerosis (Houndmills, Basingstoke, England) 2009;15(6):715-20.
2009: Manuel Comabella; M Fernández-Arquero; Jordi Río; A Guinea; M Fernández; M C Cenit; E G de la Concha; Xavier Montalban
HLA class I and II alleles and response to treatment with interferon-beta in relapsing-remitting multiple sclerosis.
Journal of neuroimmunology 2009;210(1-2):116-9.
2009: Marco Rovaris; Frederik Barkhof; Massimiliano Calabrese; Nicola de Stefano; F Fazekas; David H Miller; Xavier Montalban; Chris H Polman; Maria A Rocca; Alan J Thompson; Tarek A Yousry; Massimo Filippi
MRI features of benign multiple sclerosis: toward a new definition of this disease phenotype.
Neurology 2009;72(19):1693-701.
2009: Alex Rovira; Josephine Swanton; Mar Tintoré; Elena Huerga; Fredrick Barkhof; Massimo Filippi; Jette L Frederiksen; Annika Langkilde; Katherine Miszkiel; Chris Polman; Marco Rovaris; Jaume Sastre-Garriga; David Miller; Xavier Montalban
A single, early magnetic resonance imaging study in the diagnosis of multiple sclerosis.
Archives of neurology 2009;66(5):587-92.
2009: Herena Eixarch; Carmen Espejo; Alba Gómez; María José Mansilla; Mireia Castillo; Alexander Mildner; Francisco Vidal; Ramón Gimeno; Marco Prinz; Xavier Montalban; Jordi Barquinero
Tolerance induction in experimental autoimmune encephalomyelitis using non-myeloablative hematopoietic gene therapy with autoantigen.
Molecular therapy : the journal of the American Society of Gene Therapy 2009;17(5):897-905.
2009: Manuel Comabella; Carmen Domínguez; J Rio; Pilar Martín-Gallán; A Vilches; N Vilarrasa; Carmen Espejo; Xavier Montalban
Plasma chitotriosidase activity in multiple sclerosis.
Clinical immunology (Orlando, Fla.) 2009;131(2):216-22.
2009: Manuel Comabella; Jordi Río; Carmen Espejo; Mamen Ruiz de Villa; Hammad Al-Zayat; Carlos Nos; Florian Deisenhammer; Sergio E Baranzini; Lara Nonell; Cristina López; Eva Julià; Jorge R Oksenberg; Xavier Montalban
Changes in matrix metalloproteinases and their inhibitors during interferon-beta treatment in multiple sclerosis.
Clinical immunology (Orlando, Fla.) 2009;130(2):145-50.
2008: Maria Pia Sormani; Mar Tintorè; Marco Rovaris; Alex Rovira; Xavier Vidal; Paolo Bruzzi; Massimo Filippi; Xavier Montalban
Will Rogers phenomenon in multiple sclerosis.
Annals of neurology 2008;64(4):428-33.
2008: Pablo Villoslada; Beatriz Moreno; Ignacio Melero; Jose L Pablos; Gianvito Martino; Antonio Uccelli; Xavier Montalban; Jesús Avila; Serge Rivest; Laia Acarin; Stanley Appel; Samia J Khoury; Patrick L McGeer; Isidro Ferrer; Mario Delgado; Jose A Obeso; Michal Schwartz
Immunotherapy for neurological diseases.
Clinical immunology (Orlando, Fla.) 2008;128(3):294-305.
2008: R Bosnell; C Wegner; Zsigmond Tamas Kincses; Tijmen Korteweg; Federica Agosta; Olga Ciccarelli; Nicola de Stefano; A Gass; J Hirsch; Heidi Johansen-Berg; L Kappos; Frederik Barkhof; L Mancini; F Manfredonia; S Marino; David H Miller; Xavier Montalban; Jacqueline Palace; M Rocca; Christian Enzinger; Stefan Ropele; A Rovira; Stephen Smith; A Thompson; J Thornton; T Yousry; B Whitcher; Massimo Filippi; Paul Matthews
Reproducibility of fMRI in the clinical setting: implications for trial designs.
NeuroImage 2008;42(2):603-10.
2008: C Tur; M Tintoré; A Rovira; C Nos; Jordi Río; N Téllez; I Galán; H Perkal; M Comabella; J Sastre-Garriga; Xavier Montalban
Very early scans for demonstrating dissemination in time in multiple sclerosis.
Multiple sclerosis (Houndmills, Basingstoke, England) 2008;14(5):631-5.
2008: Zhaleh Khaleeli; Olga Ciccarelli; Francesco Manfredonia; Frederik Barkhof; B Brochet; Mara Cercignani; V Dousset; Massimo Filippi; Xavier Montalban; Chris Polman; Marco Rovaris; Alex Rovira; Jaume Sastre-Garriga; Machteld Vellinga; David Miller; Alan Thompson
Predicting progression in primary progressive multiple sclerosis: a 10-year multicenter study.
Annals of neurology 2008;63(6):790-3.
2008: Alejandro Horga; Xavier Montalban
FTY720 (fingolimod) for relapsing multiple sclerosis.
Expert review of neurotherapeutics 2008;8(5):699-714.
2008: Marco Rovaris; Elda Judica; Jaume Sastre-Garriga; Alex Rovira; Maria Pia Sormani; Beatrice Benedetti; Tijmen Korteweg; Nicola de Stefano; Zhaleh Khaleeli; Xavier Montalban; Frederik Barkhof; David H Miller; Chris Polman; Alan J Thompson; Massimo Filippi
Large-scale, multicentre, quantitative MRI study of brain and cord damage in primary progressive multiple sclerosis.
Multiple sclerosis (Houndmills, Basingstoke, England) 2008;14(4):455-64.
2008: Robert Goertsches; Sergio E Baranzini; Carlos Morcillo; Carlos Nos; Montse Camiña; Jorge R Oksenberg; Xavier Montalban; Manuel Comabella
Evidence for association of chromosome 10 open reading frame (C10orf27) gene polymorphisms and multiple sclerosis.
Multiple sclerosis (Houndmills, Basingstoke, England) 2008;14(3):412-4.
2008: J Jolijn Kragt; Alan J Thompson; Xavier Montalban; Mar Tintoré; J Río; Chris H Polman; Bernard Uitdehaag
Responsiveness and predictive value of EDSS and MSFC in primary progressive MS.
Neurology 2008;70(13 Pt 2):1084-91.
2008: Mar Tintoré; Alex Rovira; Jordi Río; C Tur; Raul Pelayo; Carlos Nos; Nieves Téllez; H Perkal; Manuel Comabella; Jaume Sastre-Garriga; Xavier Montalban
Do oligoclonal bands add information to MRI in first attacks of multiple sclerosis?
Neurology 2008;70(13 Pt 2):1079-83.
2008: Esther Byun; Stacy J Caillier; Xavier Montalban; Pablo Villoslada; Oscar Fernández; David Brassat; Manuel Comabella; Joanne Wang; Lisa F Barcellos; Sergio E Baranzini; Jorge R Oksenberg
Genome-wide pharmacogenomic analysis of the response to interferon beta therapy in multiple sclerosis.
Archives of neurology 2008;65(3):337-44.
2008: C Wegner; Massimo Filippi; Tijmen Korteweg; Christian F Beckmann; Olga Ciccarelli; Nicola de Stefano; Christian Enzinger; Franz Fazekas; Federica Agosta; A Gass; J Hirsch; Heidi Johansen-Berg; L Kappos; F Barkhof; Chris H Polman; L Mancini; F Manfredonia; S Marino; D H Miller; Xavier Montalban; Jacqueline Palace; M Rocca; Stefan Ropele; A Rovira; S Smith; A Thompson; J Thornton; T Yousry; Paul Matthews
Relating functional changes during hand movement to clinical parameters in patients with multiple sclerosis in a multi-centre fMRI study.
European journal of neurology : the official journal of the European Federation of Neurological Societies 2008;15(2):113-22.
2008: Manuel Comabella; David Craig; Montse Camiña-Tato; Carlos Morcillo; Cristina Lopez; Arcadi Navarro; Jordi Rio; Xavier Montalban; Roland Martin
Identification of a novel risk locus for multiple sclerosis at 13q31.3 by a pooled genome-wide scan of 500,000 single nucleotide polymorphisms.
PloS one 2008;3(10):e3490.
2008: Xinhua Yu; Dirk Koczan; Anna-Maija Sulonen; Denis A Akkad; Antje Kroner; Manuel Comabella; Gianna Costa; Daniela Corongiu; Robert Goertsches; Montserrat Camina-Tato; Hans-Jürgen Thiesen; Harald I Nyland; Sverre Mork; Xavier Montalban; Peter Rieckmann; Maria G Marrosu; Kjell-Morten Myhr; Joerg T Epplen; Janna Saarela; Saleh M Ibrahim
mtDNA nt13708A variant increases the risk of multiple sclerosis.
PloS one 2008;3(2):e1530.
2008: Rachel Farrell; Klaus Bendtzen; Antonio Bertolotto; Berwyn Clark; Manuel Comabella; Florian Deisenhammer; Anna Fogdell-Hahn; Gavin Giovannoni; Hans Peter Hartung; Bernard Hemmer; Jan Hillert; Ludwig Kappos; Joep Killestein; Raija Lindberg; Xavier Montalban; Chris Polman; Per Soelberg Sorensen
Re: Neutralizing antibodies to interferon beta-1b are not associated with disease worsening in multiple sclerosis.
The Journal of international medical research 2008;36(1):204-8; author reply 208-10.
2008: Nieves Téllez; J Alonso; J Río; Mar Tintoré; Carlos Nos; Xavier Montalban; Alex Rovira
The basal ganglia: a substrate for fatigue in multiple sclerosis.
Neuroradiology 2008;50(1):17-23.
2007: Josephine K Swanton; Alex Rovira; Mar Tintore; Daniel R Altmann; Frederik Barkhof; Massimo Filippi; Elena Huerga; Katherine A Miszkiel; Gordon T Plant; Chris H Polman; Marco Rovaris; Alan J Thompson; Xavier Montalban; David H Miller
MRI criteria for multiple sclerosis in patients presenting with clinically isolated syndromes: a multicentre retrospective study.
Lancet neurology 2007;6(8):677-86.
2007: Raul Pelayo; Mar Tintoré; Alex Rovira; Jordi Rio; Carlos Nos; Elisenda Grivé; Nieves Téllez; Manuel Comabella; Xavier Montalban
Polyregional and hemispheric syndromes: a study of these uncommon first attacks in a CIS cohort.
Multiple sclerosis (Houndmills, Basingstoke, England) 2007;13(6):731-6.
2007: Jordi Río; Mar Tintoré; Carlos Nos; Nieves Téllez; Ingrid Galán; Raul Pelayo; Xavier Montalban
Interferon beta in secondary progressive multiple sclerosis : daily clinical practice.
Journal of neurology 2007;254(7):849-53.
2007: Raul Pelayo; Mar Tintoré; Xavier Montalban; Alex Rovira; Carmen Espejo; Markus Reindl; Thomas Berger
Antimyelin antibodies with no progression to multiple sclerosis.
The New England journal of medicine 2007;356(4):426-8.
2007: Jens Kuhle; Christoph Pohl; Matthias Mehling; Gilles Edan; Mark S Freedman; Hans-Peter Hartung; Chris H Polman; David H Miller; Xavier Montalban; Frederik Barkhof; Lars Bauer; Susanne Dahms; Raija L P Lindberg; Ludwig Kappos; Rupert Sandbrink
Lack of association between antimyelin antibodies and progression to multiple sclerosis.
The New England journal of medicine 2007;356(4):371-8.
2006: Eva Julià; Xavier Montalban; Hammad Al-Zayat; Shohreh Issazadeh-Navikas; Robert Goertsches; Roland Martin; Manuel Comabella
Deficient Fas expression by CD4+ CCR5+ T cells in multiple sclerosis.
Journal of neuroimmunology 2006;180(1-2):147-58.
2006: Nieves Téllez; Jordi Río; Mar Tintoré; Carlos Nos; Ingrid Galán; Xavier Montalban
Fatigue in multiple sclerosis persists over time: a longitudinal study.
Journal of neurology 2006;253(11):1466-70.
2006: Ludwig Kappos; Chris H Polman; Mark S Freedman; Gilles Edan; H P Hartung; David H Miller; Xavier Montalban; Frederik Barkhof; L Bauer; Peter Jakobs; C Pohl; Rupert Sandbrink
Treatment with interferon beta-1b delays conversion to clinically definite and McDonald MS in patients with clinically isolated syndromes.
Neurology 2006;67(7):1242-9.
2006: Arnaud Charil; Tarek A Yousry; Marco Rovaris; Frederik Barkhof; Nicola de Stefano; Franz Fazekas; David H Miller; Xavier Montalban; Jack H Simon; Chris H Polman; Massimo Filippi
MRI and the diagnosis of multiple sclerosis: expanding the concept of "no better explanation".
Lancet neurology 2006;5(10):841-52.
2006: Mar Tintoré; Alex Rovira; Jordi Río; Carlos Nos; Elisenda Grivé; Nieves Téllez; Raul Pelayo; Manuel Comabella; Jaume Sastre-Garriga; Xavier Montalban
Baseline MRI predicts future attacks and disability in clinically isolated syndromes.
Neurology 2006;67(6):968-72.
2006: Lisa F Barcellos; Stephen Sawcer; Patricia P Ramsay; Sergio E Baranzini; Glenys Thomson; Farren Briggs; Bruce C A Cree; Ann B Begovich; Pablo Villoslada; Xavier Montalban; Antonio Uccelli; Giovanni Savettieri; Robin R Lincoln; Carolyn DeLoa; Jonathan L Haines; Margaret Pericak-Vance; Alastair Compston; Stephen L Hauser; Jorge R Oksenberg
Heterogeneity at the HLA-DRB1 locus and risk for multiple sclerosis.
Human molecular genetics 2006;15(18):2813-24.
2006: Ludwig Kappos; Jack Antel; Giancarlo Comi; Xavier Montalban; Paul O'Connor; Chris H Polman; Tomas Haas; Alexander A Korn; Goeril Karlsson; Ernst-Wilhelm Radue
Oral fingolimod (FTY720) for relapsing multiple sclerosis.
The New England journal of medicine 2006;355(11):1124-40.
2006: Nieves Téllez; Manuel Comabella; Eva Julià; Jordi Río; Mar Tintoré; Luis Brieva; Carlos Nos; Xavier Montalban
Fatigue in progressive multiple sclerosis is associated with low levels of dehydroepiandrosterone.
Multiple sclerosis (Houndmills, Basingstoke, England) 2006;12(4):487-94.
2006: Manuel A Friese; Xavier Montalban; Nick Willcox; John I Bell; Roland Martin; Lars Fugger
The value of animal models for drug development in multiple sclerosis.
Brain : a journal of neurology 2006;129(Pt 8):1940-52.
2006: Cristina López; Manuel Comabella; Hammad Al-zayat; Mar Tintoré; Xavier Montalban
Altered maturation of circulating dendritic cells in primary progressive MS patients.
Journal of neuroimmunology 2006;175(1-2):183-91.
2006: Manuel Comabella; Cristina Romera; Montse Camiña; Hector Perkal; Maria Moro; Juan C Leza; ignacio lizasoain; Mireia Castillo; Xavier Montalban
TNF-alpha converting enzyme (TACE) protein expression in different clinical subtypes of multiple sclerosis.
Journal of neurology 2006;253(6):701-6.
2006: M Rubiera; Jordi Río; Mar Tintoré; Carlos Nos; Alex Rovira; Nieves Téllez; Xavier Montalban
Neuromyelitis optica diagnosis in clinically isolated syndromes suggestive of multiple sclerosis.
Neurology 2006;66(10):1568-70.
2006: Tijmen Korteweg; Mar Tintoré; Bernard Uitdehaag; Alex Rovira; Jette Frederiksen; David Miller; Kryshani T M Fernando; Massimo Filippi; Federica Agosta; Maria Rocca; Franz Fazekas; Christian Enzinger; Paul Matthews; Allyson Parry; Chris H Polman; Xavier Montalban; Frederik Barkhof
MRI criteria for dissemination in space in patients with clinically isolated syndromes: a multicentre follow-up study.
Lancet neurology 2006;5(3):221-7.
2006: Jordi Río; Carlos Nos; Mar Tintoré; Nieves Téllez; Ingrid Galán; Raul Pelayo; Manuel Comabella; Xavier Montalban
Defining the response to interferon-beta in relapsing-remitting multiple sclerosis patients.
Annals of neurology 2006;59(2):344-52.
2005: Jordi Río; Xavier Montalban
Interferon-beta 1b in the treatment of multiple sclerosis.
Expert opinion on pharmacotherapy 2005;6(16):2877-86.
2005: SJ Camp; Valerie L Stevenson; Alan J Thompson; Gordon T Ingle; David H Miller; C Borras; B Brochet; V Dousset; M Falautano; Massimo Filippi; Nynke F Kalkers; Xavier Montalban; Chris H Polman; DW Langdon
A longitudinal study of cognition in primary progressive multiple sclerosis.
Brain : a journal of neurology 2005;128(Pt 12):2891-8.
2005: Tomàs Marquès-Bonet; Oscar Lao; Robert Goertsches; Manuel Comabella; Xavier Montalban; Arcadi Navarro
Association Cluster Detector: a tool for heuristic detection of significance clusters in whole-genome scans.
Bioinformatics (Oxford, England) 2005;21 Suppl 2():ii180-1.
2005: Jaume Sastre-Garriga; Gordon T Ingle; Marco Rovaris; Nieves Téllez; jasperse bas; Daniel R Altmann; B Benedetti; Valerie L Stevenson; Mara Cercignani; Siobhan M Leary; Frederik Barkhof; B Brochet; V Dousset; Massimo Filippi; Xavier Montalban; Nynke F Kalkers; Chris H Polman; Alex Rovira; David H Miller; Alan J Thompson
Long-term clinical outcome of primary progressive MS: predictive value of clinical and MRI data.
Neurology 2005;65(4):633-5.
2005: Robert Goertsches; Manuel Comabella; Arcadi Navarro; Hector Perkal; Xavier Montalban
Genetic association between polymorphisms in the ADAMTS14 gene and multiple sclerosis.
Journal of neuroimmunology 2005;164(1-2):140-7.
2005: Jordi Río; Mar Tintoré; Carlos Nos; Nieves Téllez; Ingrid Galán; Xavier Montalban
Interferon beta in relapsing-remitting multiple sclerosis. An eight years experience in a specialist multiple sclerosis centre.
Journal of neurology 2005;252(7):795-800.
2005: Jordi Río; Joana Porcel; Nieves Téllez; Angela Sánchez-Betancourt; Mar Tintoré; M Jesús Arévalo; Carlos Nos; Xavier Montalban
Factors related with treatment adherence to interferon beta and glatiramer acetate therapy in multiple sclerosis.
Multiple sclerosis (Houndmills, Basingstoke, England) 2005;11(3):306-9.
2005: David Miller; Frederik Barkhof; Xavier Montalban; Alan Thompson; Massimo Filippi
Clinically isolated syndromes suggestive of multiple sclerosis, part 2: non-conventional MRI, recovery processes, and management.
Lancet neurology 2005;4(6):341-8.
2005: Xavier Montalban
Primary progressive multiple sclerosis.
Current opinion in neurology 2005;18(3):261-6.
2005: David Miller; Frederik Barkhof; Xavier Montalban; Alan Thompson; Massimo Filippi
Clinically isolated syndromes suggestive of multiple sclerosis, part I: natural history, pathogenesis, diagnosis, and prognosis.
Lancet neurology 2005;4(5):281-8.
2005: Nieves Téllez; Jordi Río; Mar Tintoré; Carlos Nos; Ingrid Galán; Xavier Montalban
Does the Modified Fatigue Impact Scale offer a more comprehensive assessment of fatigue in MS?
Multiple sclerosis (Houndmills, Basingstoke, England) 2005;11(2):198-202.
2005: Mar Tintoré; Alex Rovira; Jordi Rio; Carlos Nos; Elisenda Grivé; Nieves Téllez; Raul Pelayo; Manuel Comabella; Xavier Montalban
Is optic neuritis more benign than other first attacks in multiple sclerosis?
Annals of neurology 2005;57(2):210-5.
2005: Carmen Espejo; Milena Penkowa; M Demestre; Xavier Montalban; Eva M Martínez-Cáceres
Time-course expression of CNS inflammatory, neurodegenerative tissue repair markers and metallothioneins during experimental autoimmune encephalomyelitis.
Neuroscience 2005;132(4):1135-49.
2005: Sergio E Baranzini; Parvin Mousavi; Jordi Rio; Stacy J Caillier; Althea Stillman; Pablo Villoslada; Matthew M Wyatt; Manuel Comabella; Larry D Greller; Roland Somogyi; Xavier Montalban; Jorge R Oksenberg
Transcription-based prediction of response to IFNbeta using supervised computational methods.
PLoS biology 2005;3(1):e2.
2005: Manuel Comabella; Imma Pericot; Robert Goertsches; Carlos Nos; Mireia Castillo; José Blas Navarro; Jordi Río; Xavier Montalban
Plasma osteopontin levels in multiple sclerosis.
Journal of neuroimmunology 2005;158(1-2):231-9.
2004: Xavier Montalban
Diagnosis and treatment of MS in Latin America. MS Forum Interactive Symposium at the LACTRIMS Congress, 27 August 2004, Iguazu Falls, Brazil.
International MS journal / MS Forum 2004;11(3):100-1.
2004: Carmen Espejo; Luis Brieva; G Ruggiero; Jordi Río; Xavier Montalban; Eva M Martínez-Cáceres
IFN-beta treatment modulates the CD28/CTLA-4-mediated pathway for IL-2 production in patients with relapsing-remitting multiple sclerosis.
Multiple sclerosis (Houndmills, Basingstoke, England) 2004;10(6):630-5.
2004: Manuel Comabella; Laura Altet; Francesc Peris; Pablo Villoslada; Armand Sánchez; Xavier Montalban
Genetic analysis of SLC11A1 polymorphisms in multiple sclerosis patients.
Multiple sclerosis (Houndmills, Basingstoke, England) 2004;10(6):618-20.
2004: Xavier Montalban
The pros and cons of early treatment of relapsing forms of multiple sclerosis.
Journal of neurology 2004;251 Suppl 4():IV30-4.
2004: Jordi Río; Carlos Nos; I Bonaventura; R Arroyo; D Genis; B Sureda; JR Ara; Luis Brieva; J Martín; Albert Saiz; F Sánchez López; J M Prieto; J Roquer; J F Dorado; Xavier Montalban
Corticosteroids, ibuprofen, and acetaminophen for IFNbeta-1a flu symptoms in MS: a randomized trial.
Neurology 2004;63(3):525-8.
2004: Carlos Nos; Jaume Sastre-Garriga; Cecília Borràs; Jordi Río; Mar Tintoré; Xavier Montalban
Clinical impact of intravenous methylprednisolone in attacks of multiple sclerosis.
Multiple sclerosis (Houndmills, Basingstoke, England) 2004;10(4):413-6.
2004: Jaume Sastre-Garriga; Manuel Comabella; Luis Brieva; Alex Rovira; Mar Tintoré; Xavier Montalban
Decreased MMP-9 production in primary progressive multiple sclerosis patients.
Multiple sclerosis (Houndmills, Basingstoke, England) 2004;10(4):376-80.
2004: David H Miller; Massimo Filippi; F Fazekas; J L Frederiksen; Paul Matthews; Xavier Montalban; Chris H Polman
Role of magnetic resonance imaging within diagnostic criteria for multiple sclerosis.
Annals of neurology 2004;56(2):273-8.
2004: Xavier Montalban
Overview of European pilot study of interferon beta-Ib in primary progressive multiple sclerosis.
Multiple sclerosis (Houndmills, Basingstoke, England) 2004;10 Suppl 1():S62; discussion 62-4.
2004: Pablo Villoslada; Jorge R Oksenberg; Jordi Rio; Xavier Montalban
Clinical characteristics of responders to interferon therapy for relapsing MS.
Neurology 2004;62(9):1653; author reply 1653.
2004: Jaume Sastre-Garriga; Mar Tintoré; Alex Rovira; Carlos Nos; Jordi Río; Alan J Thompson; Xavier Montalban
Specificity of Barkhof criteria in predicting conversion to multiple sclerosis when applied to clinically isolated brainstem syndromes.
Archives of neurology 2004;61(2):222-4.
2003: Robert Goertsches; Pablo Villoslada; Manuel Comabella; Xavier Montalban; Arcadi Navarro; Emilio G De-la-Concha; Rafael Arroyo; Adolfo Lopez de Munain; David Otaegui; Ricardo Palacios; Jordi Perez-Tur; Aslaug Jonasdottir; Kjartan Benediktsson; Ragnheidur Fossdal; Stephen Sawcer; Efrosini Setakis; Alastair Compston
A genomic screen of Spanish multiple sclerosis patients reveals multiple loci associated with the disease.
Journal of neuroimmunology 2003;143(1-2):124-8.
2003: Vito Lampasona; Jordi Rio; Diego Franciotta; Roberta Furlan; Carlo Avolio; Raffaella Fazio; Vito Lavolpe; Angela Vincent; Giancarlo Comi; Maria Trojano; Xavier Montalban; Gianvito Martino
Serial immunoprecipitation assays for interferon--(IFN)-beta antibodies in multiple sclerosis patients.
European cytokine network 2003;14(3):154-7.
2003: Jaume Sastre-Garriga; Alex Rovira; Jordi Río; Mar Tintoré; Elisenda Grivé; Xavier Montalban
Clinically definite multiple sclerosis after radiological Schilder-like onset.
Journal of neurology 2003;250(7):871-3.
2003: Pablo Villoslada; C Juste; Mar Tintore; V Llorenç; G Codina; Patricia Pozo-Rosich; Xavier Montalban
The immune response against herpesvirus is more prominent in the early stages of MS.
Neurology 2003;60(12):1944-8.
2003: Milena Penkowa; Carmen Espejo; Arantxa Ortega-Aznar; Juan Hidalgo; Xavier Montalban; Eva M Martínez-Cáceres
Metallothionein expression in the central nervous system of multiple sclerosis patients.
Cellular and molecular life sciences : CMLS 2003;60(6):1258-66.
2003: Jaume Sastre-Garriga; Elvira Munteis; Jordi Río; Imma Pericot; Mar Tintoré; Xavier Montalban
Unconventional therapy in multiple sclerosis.
Multiple sclerosis (Houndmills, Basingstoke, England) 2003;9(3):320-2.
2003: Imma Pericot; Luis Brieva; Mar Tintoré; Jordi Río; Jaume Sastre-Garriga; Carlos Nos; Xavier Montalban
Myelopathy in seronegative Sjögren syndrome and/or primary progressive multiple sclerosis.
Multiple sclerosis (Houndmills, Basingstoke, England) 2003;9(3):256-9.
2003: J Lechner-Scott; Ludwig Kappos; M Hofman; Chris H Polman; H Ronner; Xavier Montalban; Mar Tintore; M Frontoni; C Buttinelli; Maria Pia Amato; Maria Letizia Bartolozzi; Mark Versavel; F Dahlke; J-F Kapp; R Gibberd
Can the Expanded Disability Status Scale be assessed by telephone?
Multiple sclerosis (Houndmills, Basingstoke, England) 2003;9(2):154-9.
2003: Uma Sriram; Lisa F Barcellos; Pablo Villoslada; Jordi Rio; Sergio E Baranzini; Stacy J Caillier; Althea Stillman; Stephen L Hauser; Xavier Montalban; Jorge R Oksenberg
Pharmacogenomic analysis of interferon receptor polymorphisms in multiple sclerosis.
Genes and immunity 2003;4(2):147-52.
2003: Imma Pericot; Jordi Río; Alex Rovira; M Dolors Castellà; Mar Tintoré; Xavier Montalban
Serial gadolinium-enhanced MRI in acute attack of multiple sclerosis treated with plasma exchange.
Journal of neurology 2003;250(2):243-4.
2003: Jaume Sastre-Garriga; Mar Tintoré; Alex Rovira; Elisenda Grivé; Imma Pericot; Manuel Comabella; A J Thompson; Xavier Montalban
Conversion to multiple sclerosis after a clinically isolated syndrome of the brainstem: cranial magnetic resonance imaging, cerebrospinal fluid and neurophysiological findings.
Multiple sclerosis (Houndmills, Basingstoke, England) 2003;9(1):39-43.
2003: Mar Tintoré; Alex Rovira; Jordi Río; Carlos Nos; Elisenda Grivé; Jaume Sastre-Garriga; Imma Pericot; E Sánchez; Manuel Comabella; Xavier Montalban
New diagnostic criteria for multiple sclerosis: application in first demyelinating episode.
Neurology 2003;60(1):27-30.
2003: Milena Penkowa; Carmen Espejo; Eva M Martínez-Cáceres; Xavier Montalban; Juan Hidalgo
Increased demyelination and axonal damage in metallothionein I+II-deficient mice during experimental autoimmune encephalomyelitis.
Cellular and molecular life sciences : CMLS 2003;60(1):185-97.
2002: Isabel Mayo; Joaquín Arribas; Pablo Villoslada; Rita Alvarez DoForno; Susana Rodríguez-Vilariño; Xavier Montalban; María Rosa De Sagarra; José G Castaño
The proteasome is a major autoantigen in multiple sclerosis.
Brain : a journal of neurology 2002;125(Pt 12):2658-67.
2002: Eva M Martínez-Cáceres; Carmen Espejo; Luis Brieva; Imma Pericot; Mar Tintoré; Irene Sáez-Torres; Xavier Montalban
Expression of chemokine receptors in the different clinical forms of multiple sclerosis.
Multiple sclerosis (Houndmills, Basingstoke, England) 2002;8(5):390-5.
2002: Jordi Río; Carlos Nos; Mar Tintoré; Cecilia Borrás; Ingrid Galán; Manuel Comabella; Xavier Montalban
Assessment of different treatment failure criteria in a cohort of relapsing-remitting multiple sclerosis patients treated with interferon beta: implications for clinical trials.
Annals of neurology 2002;52(4):400-6.
2002: Carmen Espejo; Milena Penkowa; Irene Sáez-Torres; Juan Hidalgo; Agustina García; Xavier Montalban; Eva M Martínez-Cáceres
Interferon-gamma regulates oxidative stress during experimental autoimmune encephalomyelitis.
Experimental neurology 2002;177(1):21-31.
2002: Pablo Villoslada; Lisa F Barcellos; Jordi Rio; Ann B Begovich; Mar Tintore; Jaume Sastre-Garriga; Sergio E Baranzini; Pilar Casquero; Stephen L Hauser; Xavier Montalban; Jorge R Oksenberg
The HLA locus and multiple sclerosis in Spain. Role in disease susceptibility, clinical course and response to interferon-beta.
Journal of neuroimmunology 2002;130(1-2):194-201.
2002: Patricia Pozo-Rosich; Pablo Villoslada; Ana Canton; Rafael Simo; Alex Rovira; Xavier Montalban
Reversible white matter alterations in encephalopathy associated with autoimmune thyroid disease.
Journal of neurology 2002;249(8):1063-5.
2002: M Gràcia Cucurella; Alex Rovira; Elisenda Grivé; Mar Tintoré; Xavier Montalban; Julio Alonso
Serial proton spectroscopy, magnetization transfer ratio and T 2 relaxation in pseudotumoral demyelinating lesions.
NMR in biomedicine 2002;15(4):284-92.
2002: Alex Rovira; Imma Pericot; Juli Alonso; Jordi Rio; Elisenda Grivé; Xavier Montalban
Serial diffusion-weighted MR imaging and proton MR spectroscopy of acute large demyelinating brain lesions: case report.
AJNR. American journal of neuroradiology 2002;23(6):989-94.
2002: Xavier Montalban; A J Thompson
Workshop on primary progressive multiple sclerosis: meeting summary.
Multiple sclerosis (Houndmills, Basingstoke, England) 2002;8(2):177-8.
2002: Gordon T Ingle; Valerie L Stevenson; David H Miller; Siobhan M Leary; Marco Rovaris; Frederik Barkhof; B Brochet; V Dousset; Massimo Filippi; Xavier Montalban; Nynke F Kalkers; Chris H Polman; Alex Rovira; Alan J Thompson
Two-year follow-up study of primary and transitional progressive multiple sclerosis.
Multiple sclerosis (Houndmills, Basingstoke, England) 2002;8(2):108-14.
2002: Irene Sáez-Torres; Luis Brieva; Carmen Espejo; Miquel A Barrau; Xavier Montalban; Eva M Martínez-Caceres
Specific proliferation towards myelin antigens in patients with multiple sclerosis during a relapse.
Autoimmunity 2002;35(1):45-50.
2002: Eva M Martínez-Cáceres; Miquel A Barrau; Luis Brieva; Carmen Espejo; N Barberà; Xavier Montalban
Treatment with methylprednisolone in relapses of multiple sclerosis patients: immunological evidence of immediate and short-term but not long-lasting effects.
Clinical and experimental immunology 2002;127(1):165-71.
2001: Mar Tintoré; Alex Rovira; Luis Brieva; Elisenda Grivé; R Jardí; Cecilia Borrás; Xavier Montalban
Isolated demyelinating syndromes: comparison of CSF oligoclonal bands and different MR imaging criteria to predict conversion to CDMS.
Multiple sclerosis (Houndmills, Basingstoke, England) 2001;7(6):359-63.
2001: Carmen Espejo; Milena Penkowa; Irene Sáez-Torres; Jordi Xaus; Antonio Celada; Xavier Montalban; Eva M Martínez-Cáceres
Treatment with anti-interferon-gamma monoclonal antibodies modifies experimental autoimmune encephalomyelitis in interferon-gamma receptor knockout mice.
Experimental neurology 2001;172(2):460-8.
2001: Xavier Montalban; J Rio
Primary progressive multiple sclerosis.
Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology 2001;22 Suppl 2():S41-8.
2001: Milena Penkowa; Carmen Espejo; Eva M Martínez-Cáceres; Christian Bjørn Poulsen; Xavier Montalban; Juan Hidalgo
Altered inflammatory response and increased neurodegeneration in metallothionein I+II deficient mice during experimental autoimmune encephalomyelitis.
Journal of neuroimmunology 2001;119(2):248-60.
2001: I Durán; Eva M Martínez-Cáceres; Luis Brieva; Mar Tintoré; Xavier Montalban
Similar pro- and anti-inflammatory cytokine production in the different clinical forms of multiple sclerosis.
Multiple sclerosis (Houndmills, Basingstoke, England) 2001;7(3):151-6.
2000: Miquel A Barrau; Xavier Montalban; Irene Sáez-Torres; Luis Brieva; N Barberà; Eva M Martínez-Cáceres
CD4(+)CD45RO(+)CD49d(high) cells are involved in the pathogenesis of relapsing-remitting multiple sclerosis.
Journal of neuroimmunology 2000;111(1-2):215-23.
2000: Irene Sáez-Torres; Carmen Espejo; J J Pérez; N Acarín; Xavier Montalban; Eva M Martínez-Cáceres
Peptide T does not ameliorate experimental autoimmune encephalomyelitis (EAE) in Lewis rats.
Clinical and experimental immunology 2000;121(1):151-6.
2000: Alan J Thompson; Xavier Montalban; Frederik Barkhof; B Brochet; Massimo Filippi; David H Miller; Chris H Polman; Valerie L Stevenson; WI McDonald
Diagnostic criteria for primary progressive multiple sclerosis: a position paper.
Annals of neurology 2000;47(6):831-5.
2000: Valerie L Stevenson; David H Miller; Siobhan M Leary; Marco Rovaris; Frederik Barkhof; B Brochet; V Dousset; Massimo Filippi; R Hintzen; Xavier Montalban; Chris H Polman; Alex Rovira; J de Sa; Alan J Thompson
One year follow up study of primary and transitional progressive multiple sclerosis.
Journal of neurology, neurosurgery, and psychiatry 2000;68(6):713-8.
2000: Xavier Montalban; I Durán; Jordi Río; Irene Sáez-Torres; Mar Tintoré; Eva M Martínez-Cáceres
Can we predict flu-like symptoms in patients with multiple sclerosis treated with interferon-beta?
Journal of neurology 2000;247(4):259-62.
2000: Mar Tintoré; Alex Rovira; M J Martínez; Jordi Rio; P Díaz-Villoslada; Luis Brieva; Cecilia Borrás; Elisenda Grivé; Jaume Capellades; Xavier Montalban
Isolated demyelinating syndromes: comparison of different MR imaging criteria to predict conversion to clinically definite multiple sclerosis.
AJNR. American journal of neuroradiology 2000;21(4):702-6.
1999: I Durán; Eva M Martínez-Cáceres; Jordi Río; N Barberà; ME Marzo; Xavier Montalban
Immunological profile of patients with primary progressive multiple sclerosis. Expression of adhesion molecules.
Brain : a journal of neurology 1999;122 ( Pt 12)():2297-307.
1999: Alex Rovira; Juli Alonso; G Cucurella; Carlos Nos; Mar Tintoré; Salvador Pedraza; J Rio; Xavier Montalban
Evolution of multiple sclerosis lesions on serial contrast-enhanced T1-weighted and magnetization-transfer MR images.
AJNR. American journal of neuroradiology 1999;20(10):1939-45.
1999: SJ Camp; Valerie L Stevenson; Alan J Thompson; David H Miller; C Borras; S Auriacombe; B Brochet; M Falautano; Massimo Filippi; L Hérissé-Dulo; Xavier Montalban; E Parrcira; Chris H Polman; J de Sa; DW Langdon
Cognitive function in primary progressive and transitional progressive multiple sclerosis: a controlled study with MRI correlates.
Brain : a journal of neurology 1999;122 ( Pt 7)():1341-8.
1999: Mar Tintoré; A Rovira; D Hernández; Jordi Río; ME Marzo; Xavier Montalban
[Optic neuritis, brain stem syndromes and myelitis: rapid conversion to multiple sclerosis].
Medicina clínica 1999;112(18):693-4.
1999: Cecília Borràs; Jordi Río; Joana Porcel; M Barrios; Mar Tintoré; Xavier Montalban
Emotional state of patients with relapsing-remitting MS treated with interferon beta-1b.
Neurology 1999;52(8):1636-9.
1999: Valerie L Stevenson; David H Miller; Marco Rovaris; Frederik Barkhof; B Brochet; V Dousset; V Dousset; Massimo Filippi; Xavier Montalban; Chris H Polman; Alex Rovira; J de Sa; Alan J Thompson
Primary and transitional progressive MS: a clinical and MRI cross-sectional study.
Neurology 1999;52(4):839-45.
1998: Eva M Martínez-Cáceres; Jordi Río; Miquel A Barrau; I Durán; Cecilia Borrás; Mar Tintoré; Xavier Montalban
Amelioration of flulike symptoms at the onset of interferon beta-1b therapy in multiple sclerosis by low-dose oral steroids is related to a decrease in interleukin-6 induction.
Annals of neurology 1998;44(4):682-5.
1998: Jordi Río; C Nos; ME Marzo; Mar Tintoré; Xavier Montalban
Low-dose steroids reduce flu-like symptoms at the initiation of IFNbeta-1b in relapsing-remitting MS.
Neurology 1998;50(6):1910-2.
1998: Irene Sáez-Torres; P Díaz-Villoslada; Eva M Martínez-Cáceres; Isidro Ferrer; Xavier Montalban
Gangliosides do not elicit experimental autoimmune encephalomyelitis in Lewis rats and SJL mice.
Journal of neuroimmunology 1998;84(1):24-9.
1998: S Sauleda; J Rio; Xavier Montalban; E Martinez-Caceres; J I Estebán; J Guardia
Lack of association between hepatitis G virus and multiple sclerosis.
Journal of neurology, neurosurgery, and psychiatry 1998;64(2):283.
1998: M Jordà; C Nos; I Durán; Jordi Río; Mar Tintoré; Xavier Montalban
Information searching for multiple sclerosis.
Journal of neurology, neurosurgery, and psychiatry 1998;64(2):282-3.
1997: Jordi Río; C Nos; Mar Tintoré; ME Marzo; Xavier Montalban
Recurrent Guillain-Barré syndrome and CNS demyelination.
Journal of neurology, neurosurgery, and psychiatry 1997;63(5):688-9.
1996: Carlos Nos; M Comabella; Mar Tintoré; J Rio; Agusti Codina; Xavier Montalban; A Rovira
High dose intravenous immunoglobulin does not improve abnormalities in the blood-brain barrier during acute relapse of multiple sclerosis.
Journal of neurology, neurosurgery, and psychiatry 1996;61(4):418.
1996: M Comabella; Xavier Montalban; J Serena; M Lozano; Agusti Codina
Early vocal cord paralysis in olivopontocerebellar atrophy.
Journal of neurology 1996;243(9):670-1.
1996: A Canton; R Simo; J Mesa; C Molina; A Rovira; Xavier Montalban
Central diabetes insipidus: a complication of herpes simplex encephalitis.
Journal of neurology, neurosurgery, and psychiatry 1996;61(3):325-6.
1996: M Tintore; A L Fernandez; A Rovira; X Martinez; Haner Direskeneli; M Khamashta; S Schwartz; Agusti Codina; Xavier Montalban
Antibodies against endothelial cells in patients with multiple sclerosis.
Acta neurologica Scandinavica 1996;93(6):416-20.
1996: Xavier Montalban; Mar Tintoré; Jordi Río; I Galán; Agusti Codina
[Interobserver variability in the evaluation of functional systems and Kurzke expanded disability status scale in a multiple sclerosis patient].
Revista de neurologia 1996;24(130):630-2.
1996: N Acarín; Jordi Río; A L Fernández; Mar Tintoré; I Durán; I Galán; Xavier Montalban
Different antiganglioside antibody pattern between relapsing-remitting and progressive multiple sclerosis.
Acta neurologica Scandinavica 1996;93(2-3):99-103.
1995: M Comabella; A Canton; Xavier Montalban; Agusti Codina
Iatrogenic fulminant beriberi.
Lancet 1995;346(8968):182-3.